Phase 3 Fever Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
Dengue Fever
Takeda800 enrolled7 locationsNCT06579755
Recruiting
Phase 3
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Yellow Fever Immunization
Sanofi2,440 enrolled9 locationsNCT07103148
Recruiting
Phase 2Phase 3
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Lassa Fever
Irrua Specialist Teaching Hospital1,755 enrolled4 locationsNCT06212336
Recruiting
Phase 3
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Dengue Fever
Takeda212 enrolled4 locationsNCT06665035